Tag Archives: injectable

Lenacapavir vaccine On April 17, 2026, the Government of Uganda officially launched Lenacapavir, a revolutionary long-acting injectable drug for HIV pre-exposure prophylaxis (PrEP), to prevent HIV infection. With a 99 per cent effectiveness in trials, this injection is being rolled out to high-risk groups to enhance the fight against new HIV infections. The introduction of Lenacapavir has prompted discussions regarding …

Read More »